Literature DB >> 21700208

Development of small molecule inhibitors and probes of human SUMO deconjugating proteases.

Victoria E Albrow1, Elizabeth L Ponder, Domenico Fasci, Miklós Békés, Edgar Deu, Guy S Salvesen, Matthew Bogyo.   

Abstract

Sentrin specific proteases (SENPs) are responsible for activating and deconjugating SUMO (Small Ubiquitin like MOdifier) from target proteins. It remains difficult to study this posttranslational modification due to the lack of reagents that can be used to block the removal of SUMO from substrates. Here, we describe the identification of small molecule SENP inhibitors and active site probes containing aza-epoxide and acyloxymethyl ketone (AOMK) reactive groups. Both classes of compounds are effective inhibitors of hSENPs 1, 2, 5, and 7 while only the AOMKs efficiently inhibit hSENP6. Unlike previous reported peptide vinyl sulfones, these compounds covalently labeled the active site cysteine of multiple recombinantly expressed SENP proteases and the AOMK probe showed selective labeling of these SENPs when added to complex protein mixtures. The AOMK compound therefore represents promising new reagents to study the process of SUMO deconjugation.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21700208      PMCID: PMC3131534          DOI: 10.1016/j.chembiol.2011.05.008

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  19 in total

1.  Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1.

Authors:  M Gostissa; A Hengstermann; V Fogal; P Sandy; S E Schwarz; M Scheffner; G Del Sal
Journal:  EMBO J       Date:  1999-11-15       Impact factor: 11.598

2.  Small-molecule inhibitors and probes for ubiquitin- and ubiquitin-like-specific proteases.

Authors:  Anna Borodovsky; Huib Ovaa; Wim J N Meester; Emily S Venanzi; Matthew S Bogyo; Brian G Hekking; Hidde L Ploegh; Benedikt M Kessler; Herman S Overkleeft
Journal:  Chembiochem       Date:  2005-02       Impact factor: 3.164

3.  Activity-based probes that target diverse cysteine protease families.

Authors:  Daisuke Kato; Kelly M Boatright; Alicia B Berger; Tamim Nazif; Galia Blum; Ciara Ryan; Kareem A H Chehade; Guy S Salvesen; Matthew Bogyo
Journal:  Nat Chem Biol       Date:  2005-05-24       Impact factor: 15.040

Review 4.  Emerging roles of desumoylating enzymes.

Authors:  Jung Hwa Kim; Sung Hee Baek
Journal:  Biochim Biophys Acta       Date:  2009-03

5.  SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation.

Authors:  J M Desterro; M S Rodriguez; R T Hay
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

6.  Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes.

Authors:  Alicia B Berger; Martin D Witte; Jean-Bernard Denault; Amir Masoud Sadaghiani; Kelly M B Sexton; Guy S Salvesen; Matthew Bogyo
Journal:  Mol Cell       Date:  2006-08       Impact factor: 17.970

7.  Derivitization of the C-terminus of ubiquitin and ubiquitin-like proteins using intein chemistry: methods and uses.

Authors:  Keith D Wilkinson; Tudeviin Gan-Erdene; Nagamalleswari Kolli
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

8.  SUMO-modified PCNA recruits Srs2 to prevent recombination during S phase.

Authors:  Boris Pfander; George-Lucian Moldovan; Meik Sacher; Carsten Hoege; Stefan Jentsch
Journal:  Nature       Date:  2005-06-01       Impact factor: 49.962

9.  A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex.

Authors:  M J Matunis; E Coutavas; G Blobel
Journal:  J Cell Biol       Date:  1996-12       Impact factor: 10.539

10.  Specific and covalent targeting of conjugating and deconjugating enzymes of ubiquitin-like proteins.

Authors:  Joris Hemelaar; Anna Borodovsky; Benedikt M Kessler; David Reverter; Julie Cook; Nagamallesawari Kolli; Tudev Gan-Erdene; Keith D Wilkinson; Grace Gill; Christopher D Lima; Hidde L Ploegh; Huib Ovaa
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

View more
  25 in total

1.  Covalent Tethering of Fragments For Covalent Probe Discovery.

Authors:  Stefan G Kathman; Alexander V Statsyuk
Journal:  Medchemcomm       Date:  2016-01-28       Impact factor: 3.597

2.  Development of α-helical calpain probes by mimicking a natural protein-protein interaction.

Authors:  Hyunil Jo; Nataline Meinhardt; Yibing Wu; Swapnil Kulkarni; Xiaozhen Hu; Kristin E Low; Peter L Davies; William F DeGrado; Doron C Greenbaum
Journal:  J Am Chem Soc       Date:  2012-10-11       Impact factor: 15.419

Review 3.  New approaches for dissecting protease functions to improve probe development and drug discovery.

Authors:  Edgar Deu; Martijn Verdoes; Matthew Bogyo
Journal:  Nat Struct Mol Biol       Date:  2012-01-05       Impact factor: 15.369

4.  Selective Neutral pH Inhibitor of Cathepsin B Designed Based on Cleavage Preferences at Cytosolic and Lysosomal pH Conditions.

Authors:  Michael C Yoon; Angelo Solania; Zhenze Jiang; Mitchell P Christy; Sonia Podvin; Charles Mosier; Christopher B Lietz; Gen Ito; William H Gerwick; Dennis W Wolan; Gregory Hook; Anthony J O'Donoghue; Vivian Hook
Journal:  ACS Chem Biol       Date:  2021-08-20       Impact factor: 4.634

Review 5.  Ubiquitin and Ubiquitin-like Proteins in Cancer, Neurodegenerative Disorders, and Heart Diseases.

Authors:  Jin-Taek Hwang; Ahyoung Lee; Changwon Kho
Journal:  Int J Mol Sci       Date:  2022-05-02       Impact factor: 6.208

6.  Identification and characterization of a new chemotype of noncovalent SENP inhibitors.

Authors:  Ikenna G Madu; Andrew T Namanja; Yang Su; Steven Wong; Yi-Jia Li; Yuan Chen
Journal:  ACS Chem Biol       Date:  2013-05-01       Impact factor: 5.100

Review 7.  SENP Proteases as Potential Targets for Cancer Therapy.

Authors:  Paulina Tokarz; Katarzyna Woźniak
Journal:  Cancers (Basel)       Date:  2021-04-24       Impact factor: 6.639

8.  Strategies to Identify Recognition Signals and Targets of SUMOylation.

Authors:  Elisa Da Silva-Ferrada; Fernando Lopitz-Otsoa; Valérie Lang; Manuel S Rodríguez; Rune Matthiesen
Journal:  Biochem Res Int       Date:  2012-07-01

Review 9.  Current Status of SUMOylation Inhibitors.

Authors:  Christopher M Brackett; Brian S J Blagg
Journal:  Curr Med Chem       Date:  2021       Impact factor: 4.530

10.  It takes two to tango: Ubiquitin and SUMO in the DNA damage response.

Authors:  Serena Bologna; Stefano Ferrari
Journal:  Front Genet       Date:  2013-06-11       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.